Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Justyna E Ozimek-Kulik"'
Autor:
Michelle H T Ta, Kristina G Schwensen, Sheryl Foster, Mayuresh Korgaonkar, Justyna E Ozimek-Kulik, Jacqueline K Phillips, Anthony Peduto, Gopala K Rangan
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0164193 (2016)
The disease-modifying effects of target of rapamycin complex 1 (TORC1) inhibitors during different stages of polycystic kidney disease (PKD) are not well defined. In this study, male Lewis Polycystic Kidney Disease (LPK) rats (a genetic ortholog of h
Externí odkaz:
https://doaj.org/article/5cdcf556d3324a9ea0ff5ee7834e3cc9
Autor:
Rachael F. Kermond, Justyna E. Ozimek-Kulik, Siah Kim, Stephen I. Alexander, Deirdre Hahn, Alison Kesson, Nicholas Wood, Hugh J. McCarthy, Anne M. Durkan
Publikováno v:
Pediatric nephrology (Berlin, Germany).
COVID-19 disease in kidney transplant (KT) recipients is associated with increased morbidity, mortality, and hospitalization rates. Unfortunately, KT recipients also have a reduced response to SARS-CoV-2 immunization. The primary aim of this study wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f56d4d2676c45cb3b6343a5b7b15b2ce
https://pubmed.ncbi.nlm.nih.gov/35833990
https://pubmed.ncbi.nlm.nih.gov/35833990
Publikováno v:
Genes, Vol 12, Iss 1762, p 1762 (2021)
Genes
Genes
The exponential rise in our understanding of the aetiology and pathophysiology of genetic cystic kidney diseases can be attributed to the identification of cystogenic genes over the last three decades. The foundation of this was laid by positional cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e3d28e1dff732cacd2d7cd4e9126044
https://www.mdpi.com/2073-4425/12/11/1762
https://www.mdpi.com/2073-4425/12/11/1762
Autor:
Kristina G. Schwensen, Anthony Peduto, Michelle H. T. Ta, Jacqueline K. Phillips, Sheryl Foster, Gopala K. Rangan, Justyna E Ozimek-Kulik, Mayuresh S. Korgaonkar
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0164193 (2016)
PLoS ONE
PLoS ONE
The disease-modifying effects of target of rapamycin complex 1 (TORC1) inhibitors during different stages of polycystic kidney disease (PKD) are not well defined. In this study, male Lewis Polycystic Kidney Disease (LPK) rats (a genetic ortholog of h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa7e94099bff7877cf3056c383e60e80
http://europepmc.org/articles/PMC5056751?pdf=render
http://europepmc.org/articles/PMC5056751?pdf=render